寻求最佳治疗:索非布韦和利巴韦林治疗慢性丙型肝炎的系统评价

Journal For International Medical Graduates Pub Date : 2023-09-19 DOI:10.56570/jimgs.v2i2.126

None Monica Devi Yerramsetti, None Olawale O Olanisa, None Payal Jain, None Qasim S Khan, None Abhijith C Vemulapalli, None Abanob A Elias, None Samia Rauf Butt

{"title":"寻求最佳治疗:索非布韦和利巴韦林治疗慢性丙型肝炎的系统评价","authors":"None Monica Devi Yerramsetti, None Olawale O Olanisa, None Payal Jain, None Qasim S Khan, None Abhijith C Vemulapalli, None Abanob A Elias, None Samia Rauf Butt","doi":"10.56570/jimgs.v2i2.126","DOIUrl":null,"url":null,"abstract":"Chronic Hepatitis C (CHC) infection leads to liver cirrhosis, liver failure and hepatocellular carcinoma. It is mostly treated with Sofosbuvir and ribavirin or in combination with other Direct-acting antivirals (DAAs)","PeriodicalId":315163,"journal":{"name":"Journal For International Medical Graduates","volume":"73 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Quest for Optimal Therapy: Sofosbuvir and Ribavirin in Chronic Hepatitis C - A Systematic Review\",\"authors\":\"None Monica Devi Yerramsetti, None Olawale O Olanisa, None Payal Jain, None Qasim S Khan, None Abhijith C Vemulapalli, None Abanob A Elias, None Samia Rauf Butt\",\"doi\":\"10.56570/jimgs.v2i2.126\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Chronic Hepatitis C (CHC) infection leads to liver cirrhosis, liver failure and hepatocellular carcinoma. It is mostly treated with Sofosbuvir and ribavirin or in combination with other Direct-acting antivirals (DAAs)\",\"PeriodicalId\":315163,\"journal\":{\"name\":\"Journal For International Medical Graduates\",\"volume\":\"73 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal For International Medical Graduates\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.56570/jimgs.v2i2.126\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal For International Medical Graduates","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56570/jimgs.v2i2.126","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

慢性丙型肝炎(CHC)感染可导致肝硬化、肝功能衰竭和肝细胞癌。它主要是用索非布韦和利巴韦林或与其他直接作用抗病毒药物(DAAs)联合治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Quest for Optimal Therapy: Sofosbuvir and Ribavirin in Chronic Hepatitis C - A Systematic Review

Chronic Hepatitis C (CHC) infection leads to liver cirrhosis, liver failure and hepatocellular carcinoma. It is mostly treated with Sofosbuvir and ribavirin or in combination with other Direct-acting antivirals (DAAs)

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal For International Medical Graduates

自引率

0.00%

发文量